Light-induced expression of gRNA allows for optogenetic gene editing of T lymphocytes <i>in vivo</i>
There is currently a lack of tools capable of perturbing genes in both a precise and a spatiotemporal fashion. The flexibility of CRISPR (clustered regularly interspaced short palindromic repeats), coupled with light's unparalleled spatiotemporal resolution deliverable from a controllable source, makes optogenetic CRISPR a well-suited solution for precise spatiotemporal gene perturbations. Here, we present a new optogenetic CRISPR tool (Blue Light-inducible Universal VPR-Improved Production of RGRs, BLU-VIPR) that diverges from prevailing split-Cas design strategies and instead focuses on optogenetic regulation of guide RNA (gRNA) production. We engineered BLU-VIPR around a new potent blue-light activated transcription factor (VPR-EL222) and ribozyme-flanked gRNA. The BLU-VIPR design is genetically encoded and ensures precise excision of multiple gRNAs from a single messenger RNA transcript. This simplified spatiotemporal gene perturbation and allowed for several types of optogenetic CRISPR, including indels, CRISPRa, and base editing. BLU-VIPR also worked in vivo with cells previously intractable to optogenetic gene editing, achieving optogenetic gene editing in T lymphocytes in vivo.
Authors
- Alexander Espinosa (ORCID: https://orcid.org/0000-0003-1107-776X)
- Tilen Tršelič (ORCID: https://orcid.org/0009-0006-0316-8847)
- Gary L. Bowlin (ORCID: https://orcid.org/0000-0003-0917-8203)
- William A. Nyberg (ORCID: https://orcid.org/0000-0002-9982-1305)
- Diego Velasquez Pulgarin
- Nathalie Pelo
- Lin Ferrandiz
Institutions
- St. Jude Children's Research Hospital (US)
- Karolinska University Hospital (SE)
- University of California, San Francisco (US)
- Karolinska Institutet (SE)
- University of Memphis (US)
Publication Details
- Journal
- Nucleic Acids Research
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1093/nar/gkaf213
- Citations
- 5
- Primary Topic
- CRISPR and Genetic Engineering
- Type
- article
- Field-Weighted Citation Impact
- 4.03
Funders
- Whitaker Foundation
- Cancerfonden
- Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
- National Institutes of Health